Cormorant Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $68.8M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $34.5M | Sell |
|
|||||
|
2023
Q3 | $55.6M | Buy |
|
|||||
|
2023
Q2 | $27.8M | Hold |
|
|||||
|
2023
Q1 | $10.7M | Buy |
|
|||||
|
2022
Q4 | $5.1M | Hold |
|
|||||
|
2022
Q3 | $5.75M | Hold |
|
|||||
|
2022
Q2 | $8.47M | Hold |
|
|||||
|
2022
Q1 | $8.87M | Sell |
|
|||||
|
2021
Q4 | $20.3M | Sell |
|
|||||
|
2021
Q3 | $84.7M | Hold |
|
|||||
|
2021
Q2 | $86M | Sell |
|
|||||
|
2021
Q1 | $105M | Hold |
|
|||||
|
2020
Q4 | $148M | Buy |
|